Clinical Trial: A Post-marketing, Open-label, Non-comparative, Multi-center Clinical Investigation to Evaluate the Effectiveness and Safety of the Medical Device "Alexa Volume" (DIACO BIOFARMACEUTICI S.r.l., Italy) Based on Cross-linked Hyaluronic Acid for Correction of the Midface Volume Loss.

U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT06984419) titled 'A Post-marketing, Open-label, Non-comparative, Multi-center Clinical Investigation to Evaluate the Effectiveness and Safety of the Medical Device "Alexa Volume" (DIACO BIOFARMACEUTICI S.r.l., Italy) Based on Cross-linked Hyaluronic Acid for Correction of the Midface Volume Loss.' on May 14.

Brief Summary: This is a post-marketing, open-label, non-comparative, multi-center clinical investigation to evaluate the effectiveness and safety of the medical device "Alexa Volume" (DIACO BIOFARMACEUTICI S.r.l., Italy), based on cross-linked hyaluronic acid, for the correction of midface volume loss. The study involved 68 female subjects across...